Sign In
Get Clay Free →

Suggestions

    Roger McIntyre

    Chief Executive Officer at Braxia Scientific Corp. & Professor at the University of Toronto

    Dr. Roger McIntyre is a prominent figure in the field of psychiatry and pharmacology, currently serving as the Chief Executive Officer of Braxia Scientific Corp. He is also a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network in Toronto, Canada.3

    Professional Achievements

    Dr. McIntyre is widely recognized for his contributions to psychiatric research and treatment:

    • He has been named one of "The World's Most Influential Scientific Minds" by Clarivate Analytics for seven consecutive years (2014-2020).23
    • He is considered the world's top-ranked depression researcher.1
    • Dr. McIntyre has authored or co-authored over 700 articles and manuscripts, and has edited several textbooks on mood disorders.3

    Research Focus

    His research primarily focuses on:

    • Characterizing the phenomenology and neurobiology of mood disorders
    • Developing novel therapeutics for mood disorders
    • Identifying rapid-acting psychotropic treatments for depression13

    Notable Positions

    In addition to his role at Braxia Scientific Corp, Dr. McIntyre holds several prestigious positions:

    • Chairman and Executive Director of the Brain and Cognition Discovery Foundation (BCDF) in Toronto
    • Director and Chair of the Scientific Advisory Board for the Depression and Bipolar Support Alliance (DBSA) in Chicago
    • Professor and Nanshan Scholar at Guangzhou Medical University
    • Adjunct Professor at Korea University's College of Medicine
    • Clinical Professor at State University of New York (SUNY) Upstate Medical University and University of California School of Medicine, Riverside23

    Education and Training

    Dr. McIntyre completed his medical degree at Dalhousie University and received his psychiatry residency training and fellowship in psychiatric pharmacology at the University of Toronto.13

    Contributions to Medical Education

    Dr. McIntyre is heavily involved in medical education:

    • He is a sought-after speaker at national and international meetings
    • He has received several teaching awards from the University of Toronto
    • He has been recognized with the Canadian Psychiatric Association (CPA) / Council of Psychiatric Continuing Education Award for Outstanding Continuing Education Activity in Psychiatry in Canada23

    Dr. McIntyre's work extends beyond research and academia. He founded the Canadian Rapid Treatment Centre of Excellence (CRTCE) and has contributed to clinical practice guidelines for treating mood disorders.2

    Highlights

    Nov 9 · biospace.com
    Braxia Scientific CEO Dr. Roger McIntyre to Join Advisory Board of ...

    Related Questions

    What are Dr. McIntyre's most significant contributions to depression research?
    How has Dr. McIntyre's work impacted the treatment of mood disorders?
    What is the Canadian Rapid Treatment Centre of Excellence, and what role does Dr. McIntyre play in it?
    How does Dr. McIntyre's work at Braxia Scientific Corp. differ from his academic roles?
    What are some of the innovative treatments Dr. McIntyre has identified for mood disorders?
    Roger McIntyre
    Roger McIntyre, photo 1
    Roger McIntyre, photo 2
    Add to my network

    Experience

    Chief Executive Officer at Braxia Scientific Corp.; Professor of Psychiatry and Pharmacology at the University of Toronto

    Education

    Fellow of the Royal College of Physicians of Canada (FRCPC), Psychiatry from University of Toronto (1993-1998); Medical degree from Dalhousie University

    Location

    Toronto, Ontario, Canada